Dementia Big
Oxeia Biopharmaceuticals, Inc., a biotechnology company, is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.
http://ift.tt/1lAh7XJ
Thursday, January 21, 2016
Oxeia accelerating development of neurometabolic treatments for concussions
Oxeia accelerating development of neurometabolic treatments for concussions:
http://ift.tt/1lAh7XJ
http://ift.tt/1lAh7XJ
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment